Synthesis and biological evaluation of novel coumarin derivatives with a 7-azomethine linkage

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 3, 2004, Pages 611-614

  Kontogiorgis, Christos A ^a   Hadjipavlou Litina, Dimitra J ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Anti inflammatory; Antioxidant; Chymotrypsin; Coumarin; LOX inhibitors; Trypsin

Indexed keywords

7 FORMYLCOUMARIN; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CARRAGEENAN; COUMARIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PAW EDEMA; PROTECTION; RAT;

STAPHYLOCOCCUS PHAGE 3A;

EID: 1642493649     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2003.11.060     Document Type: Article

References (34)

1. Larson R.A. Phytochemistry. 27:1988;969.
2. Mora A., Paya M., Rios J.L., Alcaraz M.J. Biochem. Pharmacol. 40:1990;793.
3. Hoult J.R.S., Paya M. Gen. Pharmac. 27:1996;713.
4. Khan M.S.Y., Sharma P. Indian J. Chem. 32:1993;817.
5. Kimura Y., Okuda H., Arichi S., Baba K., Kozawa M. Biochim. Biophys. Acta. 834:1985;224.
6. Neichi T., Koshihara Y., Mutora S.I. Biochim. Biophys. Acta. 753:1983;130.
7. Craven P.A., Pfanstiel J., De Rubertis F.R. J. Clin. Invest. 77:1986;850.
8. Pochet L., Doucet C., Schynts M., Thierry N., Boggetto N., Pirotte B., Jiang K.Y., Masereel B., De Tullio P., Delarge J., Reboud-Ravaux M. Esters J. Med. Chem. 39:1996;2579.
9. Pochet L., Doucet C., Dive G., Wouters J., Masereel B., Reboud-Ravaux M., Pirotte B. Bioorg. Med. Chem. 8:2000;1489.
10. Wouters J., Huygens M., Pochet L., Pirotte B., Durant F., Masereel B. Bioorg. Med. Chem. Lett. 12:1990;1109.
11. Mor A., Maillard J., Favreau C., Reboud-Ravaux M. Biochim. Biophys. Acta. 1038:2002;119.
12. Mor A., Maillard J., Favreau C., Reboud-Ravaux M. Biochim. Biophys. Acta. 1038:1990;119.
13. Doucet C., Pochet L., Thierry N., Pirotte B., Delarge J., Reboud-Ravaux M. J. Med. Chem. 42:1999;4161.
14. Egan D., O'Kennedy E., Moran E., Cox D., Prosser E., Thornes R.D. Drug. Metab. Rev. 22:1990;503.
15. Nicolaides D.N., Fylaktakidou K.C., Litinas K.E., Hadjipavlou-Litina D. J. Heterocycl. Chem. 33:1996;967.
16. Nicolaides D.N., Fylaktakidou K.C., Litinas K.E., Hadjipavlou-Litina D. Eur. J. Med. Chem. 33:1998;715.
17. Nicolaides D.N., Fylaktakidou K.C., Litinas K.E., Papageorgiou G.K., Hadjipavlou-Litina D. J. Heterocycl. Chem. 35:1998;619.
18. Day R.O., Graham G.G., Williams K.M., Brooks P.M. Drugs. 1988;643.
19. Kontogiorgis, C.; Hadjipavlou-Litina, D., submitted results.
20. Ellis G.A., Blake D.R. Ann. Rheum. Dis. 1993;241.
21. Connor D.T., Von Strandtmann M. J. Org. Chem. 38:1973;3874.
22. Von Standtmann M., Conor D., Shavel J. Jr. J. Het. Chem. 9:1972;175.
23. Ito K., Nakajima K. J. Het. Chem. 25:1988;511.
24. Geronikaki A. Farmacia. 3:1990;17.
25. Hadjipavlou-Litina D., Geronikaki A. Drug Design and Discovery. 15:1998;199.
26. Emmanuel-Giota A.A., Fylaktakidou K.C., Hadjipavlou-Litina D., Litinas K.E., Nicolaides D.N. J. Heterocycl. Chem. 38:2001;717.
27. Pontiki E., Hadjipavlou-Litina D. Arzneim. Forsch./Drug Res. 53:2003;780.
28. Summers J.B., Mazdiyasmi H., Holms J.H., Ratajczyk J.D., Dyer R., Carter G. J. Med. Chem. 30:1987;574.
29. 3) C,H.
30. Kontogiorgis C., Hadjipavlou-Litina D. J. Enzym. Inhib. Med. Chem. 18:2003;63.
31. Biobyte C-QSAR program, Biobyte corp. 201 W. Fourth Str. Suite 204, Claremont CA, 91711 USA.
32. Geronikaki A., Hadjipavlou-Lina D. Pharmazie. 48:1993;948.
33. Zladosdsky P., Maliar T. Eur. J. Med. Chem. 31:1996;669.
34. Hadjipavlou-Litina D., Geronikaki A. Arzneim. Forsh. Drug Res. 46:1996;805.